These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36979770)

  • 1. Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric Cohort.
    Iseas S; Prost D; Bouchereau S; Golubicki M; Robbio J; Oviedo A; Coraglio M; Kujaruk M; Méndez G; Carballido M; Roca E; Gros L; De Parades V; Baba-Hamed N; Adam J; Abba MC; Raymond E
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG).
    Martin D; Schreckenbach T; Ziegler P; Filmann N; Kalinauskaite G; Tinhofer I; Budach V; Gani C; Zips D; Schimek-Jasch T; Schäfer H; Grosu AL; Thomas E; Krause M; Dapper H; Combs S; Hoffmann C; Stuschke M; Walter F; Belka C; Kurth I; Hadiwikarta WW; Baumann M; Rödel C; Fokas E
    Radiother Oncol; 2022 Feb; 167():233-238. PubMed ID: 34999135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma.
    Cabel L; Jeannot E; Bieche I; Vacher S; Callens C; Bazire L; Morel A; Bernard-Tessier A; Chemlali W; Schnitzler A; Lièvre A; Otz J; Minsat M; Vincent-Salomon A; Pierga JY; Buecher B; Mariani P; Proudhon C; Bidard FC; Cacheux W
    Clin Cancer Res; 2018 Nov; 24(22):5767-5771. PubMed ID: 30054279
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinical and molecular portrait of non-metastatic anal squamous cell carcinoma.
    Iseas S; Golubicki M; Robbio J; Ruiz G; Guerra F; Mariani J; Salanova R; Cabanne A; Eleta M; Gonzalez JV; Basiletti J; Picconi MA; Masciangioli G; Carballido M; Roca E; Mendez G; Coraglio M; Abba MC
    Transl Oncol; 2021 Jun; 14(6):101084. PubMed ID: 33789221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China.
    Yuan Y; Xie WH; Li RZ; Chang H; Zeng ZF; Gao YH; Wang QX; Xiao WW
    Cancer Med; 2022 Jan; 11(1):117-127. PubMed ID: 34816622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
    Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical (chemo)radiotherapy in oropharyngeal squamous cell carcinoma: Comparison of TNM 7th and 8th staging systems.
    De Felice F; Bird T; Michaelidou A; Thavaraj S; Odell E; Sandison A; Hall G; Morgan P; Lyons A; Cascarini L; Fry A; Oakley R; Simo R; Jeannon JP; Lei M; Guerrero Urbano T
    Radiother Oncol; 2020 Apr; 145():146-153. PubMed ID: 31981964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation of a composite bio-humoral index in anal cancer patients undergoing concurrent chemoradiation.
    Franco P; Porreca A; Mantello G; Valvo F; Gasparini L; Slim N; Manfrida S; De Felice F; Gerardi MA; Vagge S; Krengli M; Palazzari E; Osti MF; Gonnelli A; Catalano G; Pittoni P; Ivaldi GB; Lupattelli M; Rosetto ME; Niespolo RM; Guido A; Durante O; Macchia G; Munoz F; El Khouzai B; Lucido MR; Arcadipane F; Casadei Gardini A; Maria D'Angelillo R; Gambacorta MA; Genovesi D; Di Nicola M; Caravatta L
    Radiother Oncol; 2022 Dec; 177():9-15. PubMed ID: 36273737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of gender and HPV status on anal squamous cell carcinoma survival.
    Baidoun F; Saad AM; Abdel-Rahman O
    Int J Colorectal Dis; 2021 Oct; 36(10):2093-2109. PubMed ID: 33787999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of radical radiotherapy combined with different regimens of chemotherapy on radiation intestinal injury in patients with non-metastatic anal squamous cell carcinoma].
    Pang XL; Liu S; Liu YP; Chen HY; He F; Zheng J; Wan XB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):977-983. PubMed ID: 34823298
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic Value of
    Hilmi M; Neuzillet C; Lefèvre JH; Svrcek M; Vacher S; Benhaim L; Dartigues P; Samalin E; Lazartigues J; Emile JF; Rigault E; Rioux-Leclercq N; de La Fouchardière C; Tougeron D; Cacheux W; Mariani P; Courtois L; Delaye M; Dangles-Marie V; Lièvre A; Bieche I
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of human papillomavirus in anal squamous cell carcinoma.
    Ravenda PS; Magni E; Botteri E; Manzotti M; Barberis M; Vacirca D; Trovato CM; Dell'Acqua V; Leonardi MC; Sideri M; Fazio N; Zampino MG
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1033-8. PubMed ID: 25209946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute organ toxicity correlates with better clinical outcome after chemoradiotherapy in patients with anal carcinoma.
    Martin D; Rödel F; von der Grün J; Rödel C; Fokas E
    Radiother Oncol; 2020 Aug; 149():168-173. PubMed ID: 32417344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy.
    Parwaiz I; MacCabe TA; Thomas MG; Messenger DE
    Clin Oncol (R Coll Radiol); 2019 Dec; 31(12):e1-e13. PubMed ID: 31301958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases.
    Virk JS; Ingle M; Podesta CM; Gujral DM; Awad Z
    Clin Otolaryngol; 2020 May; 45(3):342-349. PubMed ID: 31869000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy.
    Wakeham K; Murray L; Muirhead R; Hawkins MA; Sebag-Montefiore D; Brown S; Murphy L; Thomas G; Bell S; Whibley M; Morgan C; Sleigh K; Gilbert DC
    Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):638-649. PubMed ID: 34024700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV status and immunohistochemical analysis of p16, p53 and PD‑L1 expression as prognostic biomarkers in patients with squamous cell anal cancer receiving definitive radiotherapy/chemoradiotherapy.
    Balci Topuz B; Sert F; Sezak M; Soylu M; Yalman D; Ozkok S
    Oncol Lett; 2024 Aug; 28(2):395. PubMed ID: 38966586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of HPV combined p16 status in patients with anal squamous cell carcinoma: a meta-analysis.
    Sun G; Dong X; Tang X; Qu H; Zhang H; Zhao E
    Oncotarget; 2018 Jan; 9(8):8081-8088. PubMed ID: 29487716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of human papillomavirus infection in anal squamous cell carcinoma: analysis of the national cancer data base.
    Jhaveri J; Rayfield L; Liu Y; Chowdhary M; Cassidy RJ; Madden NA; Tanenbaum DG; Gillespie TW; Patel PR; Patel KR; Landry JC
    J Gastrointest Oncol; 2017 Dec; 8(6):998-1008. PubMed ID: 29299360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.